When recording your heartbeat, look out for skipped beats, extra beats, or long pauses between beats, that can feel like ...

Stepping back into competitive sports after heart surgery sounds understandable, but for these athletes, it’s just part of ...

Gomekli showed an 87% overall response rate in pediatric low-grade glioma with MAPK pathway activation, with a recommended ...

Adverse changes in the heart’s structure and function are common in people with chronic kidney disease (CKD), warranting mitigating therapies.

Greg Marshall had dreamt of becoming a Royal Marine - but developed heart failure and was then given a medical device that ...

Shopping. Traveling. Planning family gatherings. The stress of the holiday season can make you feel like you need to slip ...

FDA label expansion makes selumetinib the second MEK inhibitor approved for adults with neurofibromatosis type 1-associated ...

Right now, the HALT Study is underway to provide the substantial evidence of effectiveness necessary for the full FDA approval of Felycin-CA1 (referred to as TRIV202 in HALT) for the management of ...

Sen. John Fetterman says he has returned home to his family in Pennsylvania after being hospitalized due to what his office said was a ventricular fibrillation flare-up that caused ...

New investor AXA IM Alts joins upsized Series B round to support clinical advancement and expand global health impact of ninerafaxstat, a novel ...

Sudden Cardiac Arrest (SCA) is the most unfortunate complication of a heart attack where in a normally beating heart comes to a complete stand still in seconds to a few minutes. Thankfully it is a ...

The FDA has approved selumetinib (Koselugo) for the treatment of adult patients with neurofibromatosis type 1 (NF1) who have ...